Valeur Intrinsèque du S&P et Nasdaq Contactez-nous
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Retour aux actions

Krystal Biotech, Inc. KRYS NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
85/100
4/7 Pass
SharesGrow Intrinsic Value
$949.71
+251.7%
Analyst Price Target
$311.00
+15.2%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Krystal Biotech, Inc. (KRYS), dont 10 achats et 37 ventes. Le total des achats d'initiés s'élève à $5.68M et le total des ventes d'initiés à $8.5M.

Les initiés notables ayant une activité récente comprennent Krishnan Krish S, Krishnan Suma, Romano Kathryn. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — KRYS

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-03-04 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Vente Informative 920 $266.56 $245.23K 1,475,253
2026-03-04 Krishnan Suma 10 Percent Owner, Officer: President, R&d Vente Informative 1,700 $266.42 $452.92K 1,403,155
2026-03-02 Romano Kathryn Chief Accounting Officer Vente Informative 750 $267.60 $200.7K 22,366
2026-03-01 Goux Laurent Louis Jean EVP, Head of International Inconnu 19,000 $52.21 $991.99K -
2026-03-01 Thomas John Charles EVP, General Counsel Inconnu 32,400 $52.21 $1.69M -
2026-02-27 Janney Daniel Director Vente Informative 2,373 $276.17 $655.34K 73,293
2026-02-27 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Exercice d'Options (Vente) 26,250 - - -
2026-02-27 Krishnan Suma 10 Percent Owner, Officer: President, R&d Exercice d'Options (Vente) 22,500 - - -
2026-02-27 Romano Kathryn Chief Accounting Officer Exercice d'Options (Vente) 7,500 - - -
2026-02-26 Janney Daniel Director Vente Informative 2,638 $276.32 $728.92K 85,096
2026-02-25 Janney Daniel Director Vente Informative 700 $275.00 $192.5K 92,837
2026-02-24 Janney Daniel Director Exercice d'Options (Vente) 37,895 $2.46 $93.22K -
2026-02-19 Rossi Dino A Director Exercice d'Options 18,950 $8.79 $166.57K 97,641
2025-03-13 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Vente Informative 1,331 $179.55 $238.98K 1,463,711
2025-03-13 Krishnan Suma 10 Percent Owner, Officer: President, R&d Vente Informative 1,331 $179.55 $238.98K 1,463,711
2025-02-28 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Exercice d'Options (Vente) 12,500 - - -
2025-02-28 Krishnan Suma 10 Percent Owner, Officer: President, R&d Exercice d'Options (Vente) 7,500 - - -
2025-02-28 Romano Kathryn Chief Accounting Officer Exercice d'Options (Vente) 5,000 - - -
2025-02-27 Romano Kathryn Chief Accounting Officer Vente Informative 750 $175.22 $131.42K 12,604
2025-02-26 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Retenue Fiscale RSU 3,286 $176.39 $579.62K 1,488,711
2025-02-26 Krishnan Suma 10 Percent Owner, Officer: President, R&d Retenue Fiscale RSU 3,286 $176.39 $579.62K 1,472,596
2025-02-26 Romano Kathryn Chief Accounting Officer Retenue Fiscale RSU 2,268 $176.39 $400.05K 13,354
2024-12-13 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Vente Informative 620 $171.62 $106.41K 1,475,882
2024-12-13 Krishnan Suma 10 Percent Owner, Officer: President, R&d Vente Informative 620 $171.62 $106.41K 1,475,882
2024-09-13 Rossi Dino A Director Don (Donné) 5,000 - - 78,691
2024-09-12 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Vente Informative 1,895 $201.52 $381.88K 1,500,882
2024-09-12 Krishnan Suma 10 Percent Owner, Officer: President, R&d Vente Informative 1,895 $201.52 $381.88K 1,500,882
2024-06-30 Janney Daniel Director Attribution de RSU 5,000 $183.64 $918.2K 5,000
2024-06-30 Rossi Dino A Director Attribution de RSU 5,000 $183.64 $918.2K 5,000
2024-06-30 Gangolli Julian S Director Attribution de RSU 5,000 $183.64 $918.2K 5,000
2024-06-30 Mason Christopher Director Attribution de RSU 5,000 $183.64 $918.2K 5,000
2024-06-30 Sutherland Everett Rand Director Attribution de RSU 5,000 $183.64 $918.2K 5,000
2024-06-30 Mazzacco Catherine Director Attribution de RSU 5,000 $183.64 $918.2K 5,000
2024-06-11 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Vente Informative 1,871 $178.15 $333.31K 1,525,882
2024-06-11 Krishnan Suma 10 Percent Owner, Officer: President, R&d Vente Informative 1,871 $178.15 $333.31K 1,525,882
2024-05-20 Gangolli Julian S Director Exercice d'Options (Vente) 20,000 $22.75 $455K -
2024-03-11 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Vente Informative 800 $174.13 $139.3K 1,550,882
2024-03-11 Krishnan Suma 10 Percent Owner, Officer: President, R&d Vente Informative 800 $174.13 $139.3K 1,550,882
2024-02-29 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Attribution de RSU 35,000 - - 35,000
2024-02-29 Krishnan Suma 10 Percent Owner, Officer: President, R&d Attribution de RSU 45,000 - - 45,000
2024-02-29 Romano Kathryn Chief Accounting Officer Attribution de RSU 15,000 - - 15,000
2024-02-28 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Exercice d'Options (Vente) 12,500 - - 12,500
2024-02-28 Krishnan Suma 10 Percent Owner, Officer: President, R&d Exercice d'Options (Vente) 7,500 - - 7,500
2024-02-28 Romano Kathryn Chief Accounting Officer Vente Informative 134 $171.66 $23K 12,936
2024-02-27 Romano Kathryn Chief Accounting Officer Exercice d'Options (Vente) 1,913 $52.26 $99.97K -
2024-02-26 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Retenue Fiscale RSU 3,791 $157.00 $595.19K 1,630,547
2024-02-26 Krishnan Suma 10 Percent Owner, Officer: President, R&d Retenue Fiscale RSU 2,353 $157.00 $369.42K 1,571,853
2024-02-26 Romano Kathryn Chief Accounting Officer Exercice d'Options (Vente) 3,087 $52.26 $161.33K 1,913
2024-01-22 Romano Kathryn Chief Accounting Officer Exercice d'Options (Vente) 2,500 $52.26 $130.65K 10,000
2023-12-11 Krishnan Krish S 10 Percent Owner, Officer: President and CEO Vente Informative 100 $107.66 $10.77K 1,574,206
■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration

Les autres consultent aussi

RYTM
RYTM
Rhythm Pharmaceuticals, Inc.
$87.28
+0.54%
 APLS
APLS
Apellis Pharmaceuticals, Inc.
$40.85
+0.02%
 DCPH
DCPH
Deciphera Pharmaceuticals, Inc.
$25.59
+0.08%
 MGTX
MGTX
MeiraGTx Holdings plc
$11.29
+17.24%
 RGNX
RGNX
REGENXBIO Inc.
$9.30
+2.88%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
📧 [email protected]
📞 +65 8912 8000
Envoyez-nous un message